Esophageal Varices
What's New
Last Posted: Sep 02, 2024
- Recompensation of Chronic Hepatitis C-related decompensated cirrhosis following direct-acting antiviral therapy: Prospective Cohort study from an HCV elimination program.
Madhumita Premkumar, et al. Gastroenterology 2024 0 - Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis.
Allaire Manon, et al. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2018 0 (1) 86-94 - Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.
Sant'Antonio Emanuela, et al. American journal of hematology 2019 0 (2) 156-166 - Gastrointestinal Hemorrhage: A Manifestation of the Telomere Biology Disorders.
Himes Ryan W, et al. The Journal of pediatrics 2020 0 55-61.e4 - Extrahepatic Portal Vein Thrombosis, an Important Cause of Portal Hypertension in Children.
Grama Alina, et al. Journal of clinical medicine 2021 0 (12) - Portal vein thrombosis: A concise review (Review).
Costache Raluca S, et al. Experimental and therapeutic medicine 2021 0 (1) 759 - Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response.
Azzi Jessica, et al. Clinics and research in hepatology and gastroenterology 2022 0 (6) 101923 - [Investigation of the gene locus in autosomal polycystic kidney disease in a 21 year old female patient with congenital hepatic fibrosis and polycystic liver].
Kosztolányi Szabolcs, et al. Orvosi hetilap 2003 0 (46) 2593-6 - Apelin Association with Hepatic Fibrosis and Esophageal Varices in Patients with Chronic Hepatitis C Virus.
Soliman Lamyaa Abdellatif, et al. The American journal of tropical medicine and hygiene 2022 0 (1) 190-197 - Protective Effects of Statin Therapy in Cirrhosis Are Limited by a Common SLCO1B1 Transporter Variant.
Merkel Melissa, et al. Hepatology communications 2021 8
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: